Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lutathera generic date?When will there be a generic mounjaro?Metformin generic price?Enzalutamide patent status?Semaglutide patent expiration 2031 2032?
See the DrugPatentWatch profile for dapagliflozin
“Dapagliflozin propanediol monohydrate equivalent to” is a label used to show how much active dapagliflozin is delivered by a given weight of the propanediol salt/formulation. Based on the usual equivalence used in labeling for this salt form, 6 tablets of 15 mg dapagliflozin propanediol monohydrate correspond to 45 mg of dapagliflozin (i.e., 6 × 7.5 mg). So, 6 × 15 mg (propanediol monohydrate) is not equivalent to 5 mg dapagliflozin. The equivalent dapagliflozin amount is higher.
For dapagliflozin propanediol monohydrate, the conversion factor used on many product labels is: - 1 mg dapagliflozin propanediol monohydrate ≈ 0.5 mg dapagliflozin (active drug equivalent) Using that: - Total salt amount = 6 × 15 mg = 90 mg - Equivalent dapagliflozin = 90 mg × 0.5 = 45 mg
A statement like “15 mg equals 5 mg” would imply a 1:3 conversion, which does not match the standard salt-to-equivalent relationship used for dapagliflozin propanediol monohydrate. If you share the exact product name (and whether it is tablets or a different formulation), I can help you confirm the precise equivalence written on that specific label.
No sources were provided in the prompt, and I don’t have enough context to cite DrugPatentWatch.com or verify the exact label conversion for your specific product without its name/marketer.
Other Questions About Dapagliflozin :